 Pangene was formed within and spun-out from SRI International, formerly Stanford Research Institute, Menlo Park, CA.Zarling co-founded PGC as a spin-out company from SRI International’s pharmaceutical drug development/genomics/cancer programs in the SRI Life Sciences Division, where he was a manager and program director.PGC sold its target bio-validation services to several pharmaceutical and biotechnology companies and achieved significant revenues.